Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the “Company”), a leader in PCR-based DNA technologies, today announced that Applied DNA Clinical Labs (ADCL), the Company’s wholly-owned ...

H5N1 influenza is evolving rapidly, weakening the effectiveness of existing antibodies and increasing its potential threat to ...

The H5N1 avian influenza virus is mutating to evade immune defenses in mammals following prior infection or vaccination.

Very few humans have gone up against bird flu. But we've all dealt with seasonal flu for years. Some of our immune systems ...

Hemagglutinin, or the HA protein ... Help may also come from antibodies aimed at the other dominant protein on the surface of ...

New computational modeling of avian influenza variants’ immunoprotein interactions – developed by a research team at the University of North Carolina at Charlotte – reveals the H5N1 influenza virus is ...

Influenza viruses are named after the two key proteins on their surface: hemagglutinin (H) and neuraminidase (N). These proteins allow the virus to enter and exit host cells. Current flu vaccines work ...

Prior exposures to specific types of seasonal influenza viruses promote cross-reactive immunity against the H5N1 avian influenza virus, according to new research from the Perelman School of Medicine ...

If this occurs, H5N1 could potentially start spreading from human to human. Influenza viruses are covered with two lollipop-shaped proteins called hemagglutinin and neuraminidase, for which the ...

If this occurs, H5N1 could potentially start spreading from human to human. Influenza viruses are covered with two lollipop-shaped proteins called hemagglutinin and neuraminidase, for which the ...